Erythropoietin Reduces Death and Neurodevelopmental Impairment in Neonatal Hypoxic-Ischemic Encephalopathy
Purpose Erythropoietin (EPO) is a promising neuroprotective drug. We investigated whether EPO has beneficial effects on neurodevelopmental outcomes in infants with hypoxic-ischemic encephalopathy (HIE). Methods We retrospectively reviewed the data of 56 infants with HIE born at or after 35 weeks of...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Book |
| Published: |
Korean Society of Neonatology,
2022-11-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|